3 Stocks Warren Buffett Just Bought

In This Article:

When the stock market falls, investors can always find encouragement to stay the course by seeing relatively low portfolio turnover at Warren Buffett's Berkshire Hathaway. Berkshire had held large positions in several stocks for years. Buffett has an unrivaled investing record based on his willingness to pounce when attractive opportunities present themselves and staying focused on the long-term value of the business when Wall Street is panicking.

In the fourth quarter, Berkshire was buying more shares of Constellation Brands (NYSE: STZ), Pool (NASDAQ: POOL), and Domino's Pizza (NASDAQ: DPZ). Here's what three Fool.com contributors think about these opportunities.

A classic Buffett value stock

Jeremy Bowman (Constellation Brands): Warren Buffett's Berkshire Hathaway buys and sells stocks every quarter, typically favoring proven winners with reliable business models and evident competitive advantages.

One of Berkshire's more surprising buys recently was Constellation Brands, the diversified alcohol company best known for selling the Mexican beer brands Corona and Modelo in the U.S. The stock soared a decade ago over the span of a few years after forging a deal with Anheuser-Busch/InBev to acquire the rights to import Corona and Modelo as part of ABI's gaining regulatory permission to merge with SABMiller.

However, since that surge, the stock has been largely flat, and is essentially in the same place it was eight years ago. Constellation shares fell sharply after the company missed estimates in its third-quarter earnings report in January, and it's facing weak consumer spending like most of its peers in the alcohol industry.

Berkshire bought the stock in the fourth quarter, so it was before the recent sell-off, but the stock now looks like a solid value after that pullback, trading at a forward P/E of just 13. The stock also pays a 2.3% dividend yield.

In a number of ways, Constellation looks like a classic Buffett value stock, as shares look cheap and its stable of brands give it an economic moat, as is evidenced by its operating margins of more than 30%. However, the slow growth in the category could be a headwind, especially with tariffs potentially roiling the alcohol market.

Constellation is still delivering steady growth, targeting organic net sales growth of 2% to 5% and a 10% increase in adjusted earnings per share for the year. But investors will have to be patient as macro factors seem to be weighing on the stock. If the company can bounce back from the poor showing in January, the stock could surge from here.